BTCC / BTCC Square / Global Cryptocurrency /
Wall Street Analysts Bullish on Biotech Stocks with 29% to 165% Upside Potential

Wall Street Analysts Bullish on Biotech Stocks with 29% to 165% Upside Potential

Published:
2025-08-03 12:00:02
8
1
BTCCSquare news:

Healthcare remains a cornerstone for investors seeking durable returns, with biotech firms leading innovation in life-saving therapies. Regeneron Pharmaceuticals (REGN) emerges as a standout, with Wall Street projecting a 29% to 68% upside over the next 12 months. The company's monoclonal antibody platform, including blockbuster drug Dupixent, targets high-value indications like eczema and cancer.

Biotech's resilience during economic turbulence underscores its appeal. A second unnamed contender boasts multibagger potential, with analysts forecasting 165% returns. These growth profiles offer compelling exposure to healthcare's innovation pipeline, though market volatility remains a factor.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users